Key result
Short-term changes in depressive symptoms are linked to early CKM syndrome stage transitions.
Why the study?
The cardiovascular-kidney-metabolic (CKM) syndrome framework links cardiometabolic risk and cardiovascular disease as a continuum, and it was examined whether short-term changes in depressive symptoms are associated with early CKM syndrome stage transition.
Are short-term changes in depressive symptoms associated with early CKM syndrome stage transition in Korean adults with baseline CKM syndrome stages 0 to 2?
Are short-term changes in depressive symptoms associated with early CKM syndrome stage transition in Korean adults with baseline CKM syndrome stages 0 to 2?
Answers are grounded in this paper and cite their sources.
Short-term depressive changes may flag early CKM progression risk; leaves open whether mood interventions alter cardiometabolic trajectories.
Background and Objectives The cardiovascular-kidney-metabolic (CKM) syndrome framework links cardiometabolic risk and cardiovascular disease as a continuum. We examined whether short-term changes in depressive symptoms are associated with early CKM syndrome stage transition in adults with baseline CKM syndrome stages 0 to 2.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question. Short-term changes in depressive symptoms were evaluated for their association with early cardiovascular-kidney-metabolic syndrome stage transition in Korean adults with baseline stages 0 to 2.
Synapse has enriched 10 related papers. Consider them for comparative context: